Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control
暂无分享,去创建一个
[1] S. Dahl,et al. High‐Performance Liquid Chromatographic Determination of Levomepromazine (Methotrimeprazine) and Its Main Metabolites in Serum and Urine , 1990, Therapeutic drug monitoring.
[2] M. Thevis,et al. Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. , 2003, Journal of mass spectrometry : JMS.
[3] T. Yano,et al. A Rapid and Simultaneous Determination of Several Analgesic Antiinflammatory Agents by Capillary Zone Electrophoresis , 2003, Therapeutic drug monitoring.
[4] D. Deforce,et al. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] F. Musshoff,et al. Fully automated determination of amphetamines and synthetic designer drugs in hair samples using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2002, Journal of Chromatographic Science.
[6] A. Negrusz,et al. Determination of drugs of abuse in meconium. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[7] F. Peters,et al. Prevalence of illicit drug use in plasmapheresis donors , 2003, Vox sanguinis.
[8] H. Maurer,et al. Mass spectral and GC data of drugs, poisons, and their metabolites , 1985 .
[9] Roland F Staack,et al. Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types: A Synopsis , 2004, Therapeutic drug monitoring.
[10] J. Hirschfeld. Conceptual Framework Shifts in Immunogenetics , 1978 .
[11] F. Peters,et al. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. , 2003, Journal of mass spectrometry : JMS.
[12] H. Maurer,et al. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] W. Weinmann,et al. LC-MS-MS analysis of the neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and zuclopenthixol in hair obtained from psychiatric patients. , 2002, Journal of analytical toxicology.
[14] W. Weinmann,et al. Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] M. Bogusz,et al. Applicability of various brands of mixed-phase extraction columns for opiate extraction from blood and serum. , 1996, Journal of chromatography. B, Biomedical applications.
[16] H. Maurer,et al. Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. , 2000, Combinatorial chemistry & high throughput screening.
[17] E. Vuori,et al. Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay. , 2000, Journal of analytical toxicology.
[18] R. Ventura,et al. Validation of qualitative chromatographic methods: strategy in antidoping control laboratories. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[19] P. Marquet,et al. Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] A. Verstraete,et al. Detection Time of Drugs of Abuse in Urine , 2000, Acta clinica Belgica.
[21] H. Maurer,et al. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] H. Maurer,et al. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone. , 2003, Journal of analytical toxicology.
[23] P. Marquet,et al. Multiresidue determination method for organophosphorus pesticides in serum and whole blood by gas chromatography-mass-selective detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[24] O. Drummer,et al. LC-MS analysis of serotonergic drugs. , 2003, Journal of analytical toxicology.
[25] H. Maurer,et al. Amphetamine-derived Designer Drugs: Metabolism and Screening Procedures/Amphetamin-verwandte Designer-Drogen: Metabolismus und Screening Verfahren , 2002 .
[26] A. Pacchioni,et al. Use of High-Performance Liquid Chromatography With Diode-Array Detection After a Primary Drug Screening in Patients Admitted to the Emergency Department , 2003, Therapeutic drug monitoring.
[27] P. Marriott,et al. Application of comprehensive two-dimensional gas chromatography to drugs analysis in doping control. , 2003, Journal of chromatography. A.
[28] H. Maurer,et al. Studies on the Human Metabolism and the Toxicologic Detection of the Cough Suppressant Dropropizine in Urine Using Gas Chromatography-Mass Spectrometry , 2004, Therapeutic drug monitoring.
[29] F. Peters,et al. New designer drug 4'-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] R. Kronstrand,et al. Evaluation of electrospray ionisation liquid chromatography-tandem mass spectrometry for rational determination of a number of neuroleptics and their major metabolites in human body fluids and tissues. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[31] Bogusz Maciej. Liquid Chromatography/Mass Spectrometry in Forensic Toxicology , 2003 .
[32] C. Casari,et al. Application of solvent microextraction to the analysis of amphetamines and phencyclidine in urine. , 2001, Forensic science international.
[33] E. Vuori,et al. Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry. , 2003, Journal of analytical toxicology.
[34] D. Cooper,et al. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS. , 2003, Journal of analytical toxicology.
[35] H. Kupferschmidt,et al. Tödliches Hirnödem nach Einnahme von Ecstasy und Benzylpiperazin , 2001 .
[36] H. Maurer,et al. Screening for Detection of New Antidepressants, Neuroleptics, Hypnotics, and Their Metabolites in Urine by GC-MS Developed Using Rat Liver Microsomes , 2001, Therapeutic drug monitoring.
[37] M. Bogusz,et al. Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[38] H. Maurer,et al. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[39] H. Maurer,et al. Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[40] E. Vuori,et al. Simultaneous screening and quantitation of 18 antihistamine drugs in blood by liquid chromatography ionspray tandem mass spectrometry. , 2001, Forensic science international.
[41] H. Thompson,et al. Trace level determination of doxylamine in nonhuman primate plasma and urine by GC/NPD and HPLC. , 1984, Journal of Analytical Toxicology.
[42] R. Glennon,et al. Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. , 1986, Biochemical pharmacology.
[43] C. Jurado,et al. Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS. , 2000, Journal of analytical toxicology.
[44] H. Maurer,et al. Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[45] F. Peters,et al. Negative Ion Chemical Ionization Gas Chromatography-Mass Spectrometry and Atmospheric Pressure Chemical Ionization Liquid Chromatography-Mass Spectrometry of Low-Dosed and/or Polar Drugs in Plasma , 2002, Therapeutic drug monitoring.
[46] P. Baumann. Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors , 1996, Clinical pharmacokinetics.
[47] M Montagna,et al. Fully-automated systematic toxicological analysis of drugs, poisons, and metabolites in whole blood, urine, and plasma by gas chromatography-full scan mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[48] C. Sutheimer,et al. Detection of drugs of abuse in nails. , 1998, Journal of analytical toxicology.
[49] P. Marquet. Progress of Liquid Chromatography–Mass Spectrometry in Clinical and Forensic Toxicology , 2002, Therapeutic drug monitoring.
[50] Timothy Olah,et al. Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.
[51] R L Foltz,et al. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[52] A. Santamaría,et al. The action of anfepramone on neurochemical and behavioral markers in rats. , 1998, Proceedings of the Western Pharmacology Society.
[53] P. Marquet,et al. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. , 2003, Journal of analytical toxicology.
[54] H. Maurer,et al. Gas chromatographic-mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi derivatization using S-adenosylmethionine. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[55] E. Vuori,et al. Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. , 2001, Rapid communications in mass spectrometry : RCM.
[56] R. Clement. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites (Parts 1, 2, 3) , 1994 .
[57] S. G. Bryant,et al. Review of bupropion. , 1983, Clinical pharmacy.
[58] P. Marquet. Is LC-MS Suitable for a Comprehensive Screening of Drugs and Poisons in Clinical Toxicology? , 2002, Therapeutic drug monitoring.
[59] F. Peters,et al. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). , 2000, Toxicology letters.
[60] H. Maurer,et al. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation. , 2001, Journal of analytical toxicology.
[61] R. Wennig,et al. The antispasmodic drug mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA)--studies on the toxicological analysis of urine by FPIA and GC-MS. , 2001, Journal of analytical toxicology.
[62] R. Glennon,et al. Methcathinone: A new and potent amphetamine-like agent , 1987, Pharmacology Biochemistry and Behavior.
[63] H. Maurer,et al. Identification of cytochrome P450 enzymes involved in the metabolism of 4′-methoxy-α-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[64] Pierre Marquet,et al. Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography—diode array detection , 2003, Journal of the American Society for Mass Spectrometry.
[65] H. Maurer,et al. Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[66] C. J. Schmitt,et al. Validated electrospray liquid chromatographic–mass spectrometric assay for the determination of the mushroom toxins α- and β-amanitin in urine after immunoaffinity extraction , 2000 .
[67] C. Staub,et al. Simultaneous determination of benzodiazepines in whole blood or serum by HPLC/DAD with a semi-micro column. , 2000, Journal of pharmaceutical and biomedical analysis.
[68] Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas , 2002 .
[69] C. J. Schmitt,et al. Validated electrospray liquid chromatographic-mass spectrometric assay for the determination of the mushroom toxins alpha- and beta-amanitin in urine after immunoaffinity extraction. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[70] E Vuori,et al. Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[71] Frank T Peters,et al. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases. , 2002, Clinical chemistry.
[72] C. V. Van Peteghem,et al. Suitability testing of commercial solid-phase extraction sorbents for sample clean-up in systematic toxicological analysis using liquid chromatography-(tandem) mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[73] H. Inoue,et al. Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. , 2000, Forensic science international.
[74] H. Maurer,et al. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[75] H. Maurer,et al. New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. , 2003, Journal of mass spectrometry : JMS.
[76] F. Molaioni,et al. Detection of beta-blockers in human urine by GC-MS-MS-EI: perspectives for the antidoping control. , 2000, Journal of pharmaceutical and biomedical analysis.
[77] W. Lambert,et al. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.
[78] C. Koester,et al. Optimum methamphetamine profiling with sample preparation by solid-phase microextraction. , 2002, Journal of forensic sciences.
[79] W. Lambert,et al. Pitfalls associated with liquid chromatography/electrospray tandem mass spectrometry in quantitative bioanalysis of drugs of abuse in saliva. , 2001, Rapid communications in mass spectrometry : RCM.
[80] C. Jurado,et al. Improved solid-phase extraction method for systematic toxicological analysis in biological fluids. , 2001, Journal of analytical toxicology.
[81] W. Weinmann,et al. Tune compounds for electrospray ionisation/in-source collision-induced dissociation with mass spectral library searching. , 2001, Journal of chromatography. A.
[82] F. Pragst,et al. Use of headspace solid-phase microextraction (HS-SPME) in hair analysis for organic compounds. , 2000, Forensic science international.
[83] R. Boulieu,et al. Solid-Phase Microextraction of Human Plasma Samples for Determination of Sufentanil by Gas Chromatography–Mass Spectrometry , 2002, Therapeutic drug monitoring.
[84] D. Thieme,et al. Screening, confirmation and quantification of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[85] H. Maxeiner. Congestion bleedings of the face and cardiopulmonary resuscitation--an attempt to evaluate their relationship. , 2001, Forensic science international.
[86] Y. Hirose,et al. Quantitative analysis of tropane alkaloids in biological materials by gas chromatography-mass spectrometry. , 2002, Forensic science international.
[87] F. Peters,et al. Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography–mass spectrometry , 2002 .
[88] A. Namera,et al. Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry. , 2002, Journal of chromatographic science.
[89] H. Maurer,et al. Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[90] H. Maurer,et al. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry. , 2000, Journal of analytical toxicology.
[91] H. Maurer,et al. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation. , 1999, Journal of analytical toxicology.
[92] N. Samyn,et al. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. , 2003, Journal of analytical toxicology.
[93] F. Peters,et al. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. , 2004, Journal of mass spectrometry : JMS.
[94] E. Richelson. Pharmacokinetic interactions of antidepressants. , 1998, The Journal of clinical psychiatry.
[95] M. Moeller,et al. Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs , 2002, Therapeutic drug monitoring.
[96] F. Peters,et al. Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry. , 2002, Journal of mass spectrometry : JMS.
[97] H. Maurer,et al. New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. , 2004, Journal of mass spectrometry : JMS.
[98] J. Segura,et al. Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry. , 2002, Journal of mass spectrometry : JMS.
[99] J. Ahlner,et al. A2 (N-benzylpiperazine) a new drug of abuse in Sweden. , 2004, Journal of analytical toxicology.
[100] P. Marquet,et al. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[101] W. Thormann. Progress of capillary electrophoresis in therapeutic drug monitoring and clinical and forensic toxicology. , 2002, Therapeutic drug monitoring.
[102] D. Deforce,et al. Liquid chromatography-mass spectrometry in forensic toxicology. , 2000, Mass spectrometry reviews.
[103] E Vuori,et al. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[104] I. Vernaleken,et al. Studies on the metabolism and toxicological detection of the amphetamine-like anorectic mefenorex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[105] M. Chiarotti,et al. SPME-GC analysis of THC in saliva samples collected with "EPITOPE" device. , 2001, Forensic science international.
[106] J. Valentine,et al. GC-MS identification of sympathomimetic amine drugs in urine: rapid methodology applicable for emergency clinical toxicology. , 2000, Journal of analytical toxicology.
[107] E. Vuori,et al. Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. , 2003, Analytical chemistry.
[108] F. Peters,et al. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. , 2003, Journal of mass spectrometry : JMS.
[109] R. Ventura,et al. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[110] O. Drummer,et al. Postmortem Drug Analysis: Analytical and Toxicological Aspects , 2002, Therapeutic drug monitoring.
[111] H. Maurer. Role of Gas Chromatography–Mass Spectrometry With Negative Ion Chemical Ionization in Clinical and Forensic Toxicology, Doping Control, and Biomonitoring , 2002, Therapeutic drug monitoring.
[112] H. Maurer,et al. Studies on the metabolism and toxicological detection of the Eschscholtzia californica alkaloids californine and protopine in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[113] W. Lambert,et al. Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer. , 2000, Rapid communications in mass spectrometry : RCM.
[114] K. Tomlinson,et al. The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid. , 2002, Journal of analytical toxicology.
[115] Laurent Rivier,et al. Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysis , 2003 .
[116] Fred W. McLafferty,et al. Registry of mass spectral data , 1974 .
[117] N. Samyn,et al. Use of Alternative Specimens: Drugs of Abuse in Saliva and Doping Agents in Hair , 2002, Therapeutic drug monitoring.
[118] H. Maurer,et al. Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[119] J. Ager,et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. , 2001, The Journal of pediatrics.
[120] A. Namera,et al. Highly sensitive analysis of methamphetamine and amphetamine in human whole blood using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2001, Forensic science international.
[121] T. Kumazawa,et al. Determination of phenothiazines in human body fluids by solid-phase microextraction and liquid chromatography/tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.
[122] S. Stanley,et al. Large-volume injection gas chromatography-mass spectrometry for automated broad-spectrum drug screening in horse urine. , 2003, Journal of analytical toxicology.
[123] M. Thevis,et al. High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. , 2001, Biomedical chromatography : BMC.
[124] F. Peters,et al. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[125] K. Deventer,et al. Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry. , 2002, Biomedical chromatography : BMC.
[126] J M Hough,et al. Evaluation of electrospray transport CID for the generation of searchable libraries. , 2000, Analytical chemistry.
[127] S. Ferrara,et al. Determination of midazolam in human plasma by solid-phase microextraction and gas chromatography/mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.
[128] K. Rentsch,et al. [Fatal brain edema after ingestion of ecstasy and benzylpiperazine]. , 2001, Deutsche medizinische Wochenschrift.
[129] E. Kenndler,et al. Determination of 1,2,4-trimethylbenzene (pseudocumene) in serum of a person exposed to liquid scintillation counting solutions by GC/MS. , 1989, Journal of analytical toxicology.
[130] T. Annesley. Ion suppression in mass spectrometry. , 2003, Clinical chemistry.
[131] F. Erdmann,et al. Simultaneous screening and detection of drugs in small blood samples and bloodstains. , 2002, Forensic science international.
[132] O. Temme,et al. An analytical method for the rapid screening of organophosphate pesticides in human biological samples and foodstuffs. , 2001, Forensic science international.
[133] S. Pollak,et al. Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS , 2000, International Journal of Legal Medicine.
[134] W. Lambert,et al. Simultaneous determination of in total 17 opium alkaloids and opioids in blood and urine by fast liquid chromatography-diode-array detection-fluorescence detection, after solid-phase extraction. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[135] A. Polettini,et al. Comprehensive Drug Screening by Integrated Use of Gas Chromatography/Mass Spectrometry and Remedi HS , 2001, Therapeutic drug monitoring.
[136] F. Pragst,et al. Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography--electrospray ionization mass spectrometry. , 2001, Journal of analytical toxicology.
[137] H. Maurer,et al. Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography–mass spectrometry , 2003 .
[138] W. Külpmann,et al. High-temperature solid-phase microextraction procedure for the detection of drugs by gas chromatography-mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[139] R. Fokkens,et al. Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samples. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[140] Frank T Peters,et al. Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS. , 2003, Journal of analytical toxicology.
[141] K. Hara,et al. New method of derivatization and headspace solid-phase microextraction for gas chromatographic-mass spectrometric analysis of amphetamines in hair. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[142] T. Shinohara,et al. Systematic analysis of acid, neutral and basic drugs in horse plasma by combination of solid-phase extraction, non-aqueous partitioning and gas chromatography-mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[143] L. Benet,et al. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.
[144] F. Musshoff,et al. Fully automated determination of cannabinoids in hair samples using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2002, Journal of analytical toxicology.
[145] W. Lambert,et al. Comparison of phenyl-type columns in the development of a fast liquid chromatographic system for eighteen opiates commonly found in forensic toxicology. , 2000, Journal of chromatography. A.
[146] P. Marquet,et al. Sensitive and specific multiresidue methods for the determination of pesticides of various classes in clinical and forensic toxicology. , 2001, Forensic science international.
[147] I. Bosman,et al. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. , 2001, Forensic science international.